GOALS OF WORK: Radiotherapy (RT) for palliation of pain due to bone metastases (BM) is effective but underutilized likely due to the traditional practice of separate clinic visits for consultation, treatment planning, and RT delivery. However, recent evidence proves one RT treatment is as effective as multiple for analgesia, enabling investigation of an alternative model of RT delivery, the rapid access palliative radiotherapy program (RAPRP). MATERIALS AND METHODS: Prior to the start of the program, needs assessment was performed to determine the composition of the optimal team. Screening tools were implemented to streamline holistic, multidisciplinary assessment. An advertising strategy, treatment and research protocols, and mechanisms for patient feedback were established. After RAPRP implementation, patient outcomes such as symptom relief were tracked. MAIN RESULTS: Eighty-six patients with painful BM were referred over the 25-week pilot. Median age was 69.9 years; 64% had prostate cancer, and median performance status was 70. Patient-rated pain was on average 6.1/10 at baseline, improving to 2.6/10 by week 4 post-RT. On average, 6.2 symptoms were reported (baseline) compared to 5.2 (week 4). Team members assessed 10-100% of patients and were successful in stabilizing or improving all symptoms in >75% contacted at week 4. One hundred percent of patients surveyed were satisfied with their experience. CONCLUSIONS: Early needs assessment was advantageous in determining the optimal team and methods of assessment for our 'one-stop' BM clinic. This approach was successful in improving pain and other symptoms, and the convenience of seeing multiple providers on 1 day was appreciated by the patients.
GOALS OF WORK: Radiotherapy (RT) for palliation of pain due to bone metastases (BM) is effective but underutilized likely due to the traditional practice of separate clinic visits for consultation, treatment planning, and RT delivery. However, recent evidence proves one RT treatment is as effective as multiple for analgesia, enabling investigation of an alternative model of RT delivery, the rapid access palliative radiotherapy program (RAPRP). MATERIALS AND METHODS: Prior to the start of the program, needs assessment was performed to determine the composition of the optimal team. Screening tools were implemented to streamline holistic, multidisciplinary assessment. An advertising strategy, treatment and research protocols, and mechanisms for patient feedback were established. After RAPRP implementation, patient outcomes such as symptom relief were tracked. MAIN RESULTS: Eighty-six patients with painful BM were referred over the 25-week pilot. Median age was 69.9 years; 64% had prostate cancer, and median performance status was 70. Patient-rated pain was on average 6.1/10 at baseline, improving to 2.6/10 by week 4 post-RT. On average, 6.2 symptoms were reported (baseline) compared to 5.2 (week 4). Team members assessed 10-100% of patients and were successful in stabilizing or improving all symptoms in >75% contacted at week 4. One hundred percent of patients surveyed were satisfied with their experience. CONCLUSIONS: Early needs assessment was advantageous in determining the optimal team and methods of assessment for our 'one-stop' BM clinic. This approach was successful in improving pain and other symptoms, and the convenience of seeing multiple providers on 1 day was appreciated by the patients.
Authors: E Chow; R Wong; M Vachon; R Connolly; L Andersson; E Szumacher; E Franssen; C Danjoux Journal: Support Care Cancer Date: 2000-09 Impact factor: 3.603
Authors: C Danjoux; E Chow; A Drossos; L Holden; C Hayter; M Tsao; T Barnes; E Sinclair; M Farhadian Journal: Support Care Cancer Date: 2005-04-23 Impact factor: 3.603
Authors: Peiman Haddad; Paula Wilson; Rebecca Wong; Diane Williams; Neena Sharma; Freidele Soban; Michael McLean; Wilfred Levin; Andrea Bezjak Journal: Support Care Cancer Date: 2003-06-17 Impact factor: 3.603
Authors: Sanders Chang; Peter May; Nathan E Goldstein; Juan Wisnivesky; Kenneth Rosenzweig; R Sean Morrison; Kavita V Dharmarajan Journal: J Palliat Med Date: 2017-11-30 Impact factor: 2.947
Authors: Winter Spence; Sunita Ghosh; Megan Palen; Alex Liska; Vincent Ha; Rebecca Wong; Fleur Huang Journal: Support Care Cancer Date: 2020-02-07 Impact factor: 3.603
Authors: Sharon M Watanabe; Alysa Fairchild; Edith Pituskin; Patricia Borgersen; John Hanson; Konrad Fassbender Journal: Support Care Cancer Date: 2012-11-17 Impact factor: 3.603
Authors: J O Kim; N Hanumanthappa; Y T Chung; J Beck; R Koul; B Bashir; A Cooke; A Dubey; J Butler; M Nashed; W Hunter; A Ong Journal: Curr Oncol Date: 2020-08-01 Impact factor: 3.677
Authors: Birgitt van Oorschot; Michael Schuler; Anke Simon; Ursula Schleicher; Hans Geinitz Journal: Strahlenther Onkol Date: 2011-07-22 Impact factor: 3.621
Authors: Yolanda D Tseng; Monica S Krishnan; Joshua A Jones; Adam J Sullivan; Daniel Gorman; Allison Taylor; Michael Pacold; Barbara Kalinowski; Harvey J Mamon; Janet Abrahm; Tracy A Balboni Journal: Pract Radiat Oncol Date: 2013-11-20
Authors: Shilo Lefresne; Eric Berthelet; Rosemary Cashman; Karen Levy; Mitchel Liu; Hannah Carolan; Michael McKenzie; Paula Kostuik; Robert Olson Journal: Support Care Cancer Date: 2014-07-08 Impact factor: 3.603